Sandoz Inc. Commends FDA's Draft Guidance on Biosimilar Development
2026-02-02
PubComNonGov2026-02-02
Carter Struck
WASHINGTON, Feb. 2 -- Sandoz Inc. issued a public comment letter to the U.S. Food and Drug Administration (FDA), expressing strong support for the agency's draft guidance on the assessment of comparat . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Feb. 2 -- Sandoz Inc. issued a public comment letter to the U.S. Food and Drug Administration (FDA), expressing strong support for the agency's draft guidance on the assessment of comparat . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026